News
TNXP
8.07
-9.43%
-0.84
Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Could Be Quite Risky
Simply Wall St · 22h ago
Weekly Report: what happened at TNXP last week (0928-1002)?
Weekly Report · 1d ago
Tonix Pharma Faces Generic TONMYA Patent Challenge
TipRanks · 3d ago
Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic TONMYA On Oct 1; Paragraph IV Certification Challenges Four TONMYA Patents Listed In FDA Orange Book; Co Intends To Enforce TONMYA Intellectual Property Rights
Benzinga · 3d ago
Tonix Pharma (TNXP) Receives a Buy from Alliance Global Partners
TipRanks · 09/28 13:15
Weekly Report: what happened at TNXP last week (0921-0925)?
Weekly Report · 09/28 09:10
Tonix Pharma expands TONMYA Medicare Part D coverage
TipRanks · 09/22 11:30
Analysts Are Bullish on Top Healthcare Stocks: ALX Oncology Holdings (ALXO), Tonix Pharma (TNXP)
TipRanks · 09/21 14:01
Weekly Report: what happened at TNXP last week (0914-0918)?
Weekly Report · 09/21 09:10
Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Tonix Pharma (TNXP) and Solventum Corporation (SOLV)
TipRanks · 09/15 08:00
Weekly Report: what happened at TNXP last week (0907-0911)?
Weekly Report · 09/14 09:10
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears
NASDAQ · 09/12 02:01
Tonix Names Englese Chief Commercial Officer To Expand TONMYA Reach
NASDAQ · 09/08 15:52
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Tyra Bioscience (TYRA) and Becton Dickinson (BDX)
TipRanks · 09/08 13:10
Tonix Pharma Appoints New Chief Commercial Officer
TipRanks · 09/08 11:29
Press Release: Tonix Pharmaceuticals Promotes -2-
Dow Jones · 09/08 11:00
Press Release: Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Dow Jones · 09/08 11:00
Weekly Report: what happened at TNXP last week (0831-0904)?
Weekly Report · 09/07 09:10
Dollar General, TeraWulf, Schwab, Tonix, Warner Bros Shock
TipRanks · 09/05 13:01
Tonix Pharma CEO Makes Bold Insider Move With Fresh Stock Purchase
TipRanks · 09/01 02:01
More
Webull provides a variety of real-time TNXP stock news. You can receive the latest news about Tonix Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.